Properties
Description
Epertinib is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells. It targets EGFR, HER2, and HER4.
Molecular Formula
C30H27ClFN5O3
Targets
EGFR: 1.48 ± 0.0 nM; HER2: 7.15 ± 0.5 nM; HER4: 2.49 ± 0.1 nM
Identity
Confirmed by NMR/HPLC/MS.
Applications
Epertinib can be used in studies evaluating its effects as a dual inhibitor of EGFR and HER2 in cancer treatment.